Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

80.71
Delayed Data
As of Sep 28
 -0.17 / -0.21%
Today’s Change
67.88
Today|||52-Week Range
88.48
-4.21%
Year-to-Date
Novo Nordisk Takes Axe to Workforce as Growth Falters
6:58am / TheStreet.com - Paid Partner Content
Pfizer (PFE) to Stay Together as a Single Company After All
Sep 27 / Zacks.com - Paid Partner Content
Jim Cramer's Top Takeaways: Nike, Newell Brands, Paychex, Radius Health
6:06am / TheStreet.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Upgraded at Goldman, Jim Cramer Weighs In
Sep 27 / TheStreet.com - Paid Partner Content
Biosimilars in Limelight on FDA Approval of Amgen Drug
Sep 27 / Zacks.com - Paid Partner Content
Eli Lilly rises on Goldman recommendation
Sep 27 / FT.com - Paid Partner Content
Eli Lilly (LLY) Stock Higher, Upgraded at Goldman
Sep 27 / TheStreet.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know
Sep 27 / MotleyFool.com - Paid Partner Content
Analysts' Actions -- AutoZone, Eli Lilly, J.M. Smucker, Toll Brothers and More
Sep 27 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close80.88
Today’s open80.84
Day’s range80.02 - 81.17
Volume2,467,803
Average volume (3 months)3,789,433
Market cap$89.3B
Dividend yield2.53%
Data as of 09/28/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+4.58%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.75%
P/E ratio34.8
Price/Sales4.50
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.11-0.25%
BMYBristol-Myers Squibb-0.65-1.17%
AZNAstraZeneca+0.21+0.62%
AGNAllergan-1.57-0.66%
Data as of 09/28/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.96
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Search for Jobs